Dr. Daniel Ferguson is an instructor for the Geriatrics and Nutritional Sciences Division. He earned a B.S. from Emory & Henry College, Emory, VA in 2006, he earned a PhD from Wake Forest University School of Medicine, Winston-Salem, NC and is a postgraduate from Washington University School of Medicine in 2021. Dr. Ferguson’s primary research interests are focused on the role of intermediary metabolism in immune cells during the development and progression of nonalcoholic liver disease (NAFLD). NAFLD is a common pathological condition that is highly associated with metabolic syndrome, including insulin resistance and diabetes.
Dr. Ferguson’s primary research interest is focused on role of intermediary metabolism in immune cells during the development and progression of nonalcoholic steatohepatitis (NASH). NASH is a common liver disease, and macrophages, which are cells of the immune system, play a pivotal role in disease progression. Dr. Ferguson’s research will contribute to our understanding of macrophage function and NASH progression to highlight the clinical utility of targeting these cells in NASH. Ultimately, our studies may lead to new therapeutic options that will improve patient health and quality of life.